COMMUNIQUÉS West-GlobeNewswire

Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
16/10/2026
FDA expands the approved use of phentolamine ophthalmic solution 0.75% to include age-related near vision impairment, which affects millions of adults in the United States Approval supported by positive results from [...]
K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world
16/10/2026
K2 Vision has surpassed over 5,000 Light Adjustable Lens Procedures Seattle, WA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- K2 Vision has performed 5,000 Light Adjustable Lens (LAL) procedures. RxSight, the company that makes [...]
Regulated information: Disclosure of a transparency notification from BlackRock, Inc.
16/10/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 October 2026 – 6 PM CET Disclosure of a transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure [...]
Dr. Jacqueline Youtsos and ReNu Medical & Spa Congratulate Kasi Hudson on Becoming a Board Certified Dermatology Nurse Practitioner
16/10/2026
Advanced credential strengthens access to expert skin care for patients across Pittsburg, Southeast Kansas, and Southwest Missouri PITTSBURG, Kansas, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Dr. Jacqueline Youtsos, MD and the [...]
Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells
16/10/2026
New Preclinical Findings Identify Potential Strategy to Remodel Resistant Tumor State & Restore Therapeutic Vulnerability MELBOURNE, Australia, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB [...]
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
16/10/2026
PRINCETON, N.J., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 American Academy of [...]
Hemp Hop Launches Mini Pre Rolls Collection as Cannabis Multipacks Gain Momentum
16/10/2026
CHARLOTTE, N.C., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Hemp Hop, a premium THCa Dispensary brand founded in Charlotte, North Carolina, in 2018, has announced the launch of its new Mini Pre Rolls collection introducing 7 [...]
NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
16/10/2026
Why Abu Dhabi Strategy and New Banking Director Signal Bigger Global Ambition DENVER, Oct. 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) delivered a deeply human [...]
SafeSpace Global Extends Exclusive BMRT Security Agreement to Houses of Worship and Addiction Treatment Centers
16/10/2026
BMRT’s Base Molecular Resonance ™ Technology Detects the Molecular Signature of a Concealed Firearm from More Than 500 Feet Away and Identifies Drugs Inside Vehicles and Backpacks at a Distance; Expansion Adds More Than [...]
Breast Cancer Awareness Fundraiser with Prairie Cannabis
16/10/2026
Prairie Cannabis Launches Breast Cancer Awareness Fundraiser Supporting Gilda's Club Chicago Throughout October Illinois dispensary partners with nonprofit to provide free cancer support services during Breast Cancer [...]
Moleculin Announces Reverse Stock Split
16/10/2026
HOUSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation [...]
Kexing Biopharm’s Biologics License Application for Long-Acting G-CSF Candidate GB-K02 Accepted for Review
16/10/2026
SAN DIEGO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kexing Biopharm (688136.SH) recently announced that it has received a Notice of Acceptance from China’s National Medical Products Administration (NMPA) for the biologics [...]
Natural Remedies' Bacomind Advances Research on Memory and Cognitive Health With New 600-Participant Study
16/10/2026
BANGALORE, India, Oct. 16, 2026 (GLOBE NEWSWIRE) -- As interest grows in memory, focus and mental sharpness throughout life, new clinical research is exploring the potential of a centuries-old botanical ingredient to [...]
Whole Lotta Dank Debuts Dank Pack Across Alberta, Announces Nationwide Search for Cannabis Partners
16/10/2026
Backed by eight retail locations and over 125,000 deliveries completed, Whole Lotta Dank launches its first cannabis brand, advances 20+ SKUs and seeks long-term partnerships with Canadian producers CALGARY, Alberta, [...]
CHMP recommends approval of Johnson & Johnson’s TALVEY®▼ (talquetamab) plus daratumumab in earlier line treatment of relapsed/refractory multiple myeloma
16/10/2026
If approved, TALVEY ® plus daratumumab will be the only GPRC5D-targeting bispecific antibody combination therapy for relapsed or refractory multiple myeloma as early as second line CHMP recommendation based on Phase 3 [...]
Semax Peptide Introduced by Kylo Peptides for Laboratory Use
16/10/2026
Sheridan, Wyoming, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides has added Semax [ https://kylopeptides.com/product/semax/ ] to its research catalog this week. The compound is a synthetic peptide supplied only for [...]
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
16/10/2026
BOSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
16/10/2026
Former Dermavant Chief Scientific Officer led development of tapinarof, the first FDA-approved AhR agonist, from mechanistic understanding through approval and commercialization Will lead AT177 through IND-enabling [...]
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
16/10/2026
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham 32% of Revita ® participants in [...]

Pages